NEW YORK (GenomeWeb) – Response Genetics today disclosed that its stock has been delisted from the Nasdaq and will now trade on the Over-the-Counter Bulletin Board.

In late December, the company said that its shares were facing delisting for failing to meet the Nasdaq's $1 minimum bid price requirement. The company had previously been notified that it also did not meet the exchange's minimum $2.5 million in stockholders’ equity requirement

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.